**Core Concept**
The patient has hypercholesterolemia (elevated plasma cholesterol levels) and hyperglycemia (elevated blood sugar levels), which are risk factors for cardiovascular disease. Managing these conditions often involves the use of lipid-lowering and glucose-lowering medications.

**Why the Correct Answer is Right**
In this patient, a combination of lipid-lowering and glucose-lowering therapies is necessary to manage both conditions. Statins (A) are effective in lowering LDL cholesterol and can also have a modest effect on triglyceride levels. Fibrates (B) primarily lower triglyceride levels and can also increase HDL cholesterol. Nicotinic acid (C) can lower triglyceride levels, increase HDL cholesterol, and also lower LDL cholesterol. Therefore, using all three agents (D) in combination can provide a comprehensive approach to managing this patient's lipid and glucose profiles.

**Why Each Wrong Option is Incorrect**
**Option A:** While statins are effective in lowering LDL cholesterol, they do not directly address the patient's elevated triglyceride levels or glucose levels.

**Option B:** Fibrates are effective in lowering triglyceride levels, but they may not be sufficient on their own to manage this patient's elevated LDL cholesterol and glucose levels.

**Option C:** Nicotinic acid can lower triglyceride levels and increase HDL cholesterol, but it may not be as effective as statins in lowering LDL cholesterol, and it can have gastrointestinal side effects.

**Clinical Pearl / High-Yield Fact**
When managing patients with hypercholesterolemia and diabetes, it's essential to consider a combination of lipid-lowering and glucose-lowering therapies to address all aspects of cardiovascular risk.

**Correct Answer:**
✓ Correct Answer: D. All of the above